Objective: To assess outpatients' perceptions of medical care.
Methodology: A telephone survey was administered to patients treated in two different months in 2012 with a focus on socio-demographic variables, access to care, physician-patient relationships, and on the process of medical care.
Results: 804 patients were surveyed. The average time of access to care was 9.6 days. 78 % reported having been able to tell the doctor everything that they felt, 60 % reported that the doctor explained what they had, and one in four patients said that the doctor asked about their families. 30 % felt complete relief after medical care. The average rating of care was 7.9 (SD ±1.7). Variables related to the highest ratings were: having been able to tell that doctor everything that they felt (OR 7.5 CI 95 % 1.8-31), having been examined (OR 7.5 CI95 % 1.5-38.5), that the doctor explained what they had (OR 5.2 CI 95 % 1.8-15), that the doctor asked about the family (OR 5.8 CI95 % 2.1-16.1), and if doctor had treated them formerly (OR 3.5 CI95 % 1.4-8.6).
Conclusions: Extensive communication with the patient is as important as dealing with the disease in the medical act.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Prediction of dementia using CT imaging in stroke (PRODUCTS).
Eur Stroke J
March 2025
Institute of Cardiovascular and Metabolic Sciences, University of Glasgow, Glasgow, UK.
Introduction: A better understanding of who will develop dementia can inform patient care. Although MRI offers prognostic insights, access is limited globally, whereas CT-imaging is readily available in acute stroke. We explored the prognostic utility of acute CT-imaging for predicting dementia.
View Article and Find Full Text PDFEthical issues surrounding the implementation of long-acting injectable antiretroviral therapy in sub-Saharan Africa.
Int Health
March 2025
Department of Global Health and Development, London School of Hygiene and Tropical Medicine, P.O Box WC1E 7HT, London, UK.
Background: This article discusses the ethical issues surrounding the integration of long-acting injectable antiretroviral therapy (LA-ART) in the programmatic management of human immunodeficiency virus (HIV). As the medical landscape evolves, implementing LA-ART introduces many ethical issues that should be considered for the success of scale-up in diverse settings.
Methods: This article examines key issues such as bioethical concerns around the rollout of LA-ART, including regulatory requirements, a person's autonomy, informed consent, privacy and confidentiality; the societal implications of providing LA-ART, including the impact on stigma and discrimination; ethics around who receives LA-ART, financial accessibility, equitable access, inclusive decision-making and cultural sensitivity; and the ethics of providing an expensive intervention, including cost-effectiveness, supply chain sustainability and resource allocation.
Large Language Model-Based Critical Care Big Data Deployment and Extraction: Descriptive Analysis.
JMIR Med Inform
March 2025
Department of Critical Care Medicine, Beijing Tiantan Hospital, Capital Medical University, No.119 Nansihuanxi Road, Fengtai District, Beijing, 100070, China, 86 17611757717.
Background: Publicly accessible critical care-related databases contain enormous clinical data, but their utilization often requires advanced programming skills. The growing complexity of large databases and unstructured data presents challenges for clinicians who need programming or data analysis expertise to utilize these systems directly.
Objective: This study aims to simplify critical care-related database deployment and extraction via large language models.
The Effect of 50% Dextrose on Serum Glucose Levels in Adult Hypoglycemic Patients: A Prospective Observational Study.
Cureus
March 2025
Emergency Medicine, Nizwa Hospital, Nizwa, OMN.
Objective: This study aimed to observe changes in serum glucose levels following the administration of 50 mL of 50% dextrose solution (D50) in hypoglycemic patients. Specifically, we seek to determine the prevalence of rebound hyperglycemia episodes, the peak effect, and the duration of action of a single dose of 50 mL D50.
Method: This prospective observational study was conducted at four emergency departments (two tertiary care hospitals and two secondary care hospitals) in Oman over a three-year period, from May 1, 2019, to April 30, 2022.
From the Masterclasses in Dermatology 2024 Meeting: Updates in Psoriasis Treatments.
J Clin Aesthet Dermatol
February 2025
Ms. Romanelli and Dr. Gottlieb are with the Department of Dermatology and Department of Medicine, Division of Rheumatology at Icahn School of Medicine at Mount Sinai in New York, New York.
Psoriasis (PsO) is an immune-mediated, chronic inflammatory skin disease that significantly impairs quality of life. Its treatment landscape is rapidly evolving, providing better disease control. Here, we highlight updates in biologics, obtaining coverage for biologics under Medicare, the PsO-to-psoriatic arthritis (PsA) transition, and orally administered drugs, as presented at the 2024 Masterclass in Dermatology in Puerto Rico.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!